Drug: XOLAIR Injury: Nasopharyngitis Quarter: 2016Q3
Total Records: 171 Number of Pages: 9
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
113255884 | XOLAIR | Nasopharyngitis | ROCHE | 64.31 YR | M | 0 | 20160816 | CA |
114089486 | XOLAIR | Nasopharyngitis | ROCHE | 51.50 YR | F | 0 | 20160825 | CA |
114089848 | XOLAIR | Nasopharyngitis | ROCHE | 43.92 YR | M | 0 | 20160819 | CA |
114145495 | XOLAIR | Nasopharyngitis | ROCHE | 63.54 YR | F | 0 | 20160915 | CA |
114443539 | XOLAIR | Nasopharyngitis | ROCHE | 63.76 YR | M | 0 | 20160914 | CA |
115507255 | XOLAIR | Nasopharyngitis | ROCHE | 51.93 YR | M | 0 | 20160811 | CA |
116277856 | XOLAIR | Nasopharyngitis | ROCHE | 65.19 YR | F | 0 | 20160901 | CA |
116313902 | XOLAIR | Nasopharyngitis | ROCHE | 0.00 | F | 0 | 20160719 | CA |
116624346 | XOLAIR | Nasopharyngitis | ROCHE | 71.02 YR | F | 0 | 20160923 | CA |
117046685 | XOLAIR | Nasopharyngitis | NOVARTIS | 79.11 YR | M | 0 | 20160802 | COUNTRY NOT SPECIFIED |
117198127 | XOLAIR | Nasopharyngitis | ROCHE | 40.95 YR | M | 0 | 20160907 | CA |
117451868 | XOLAIR | Nasopharyngitis | ROCHE | 12.74 YR | F | 0 | 20160712 | CA |
117570305 | XOLAIR | Nasopharyngitis | ROCHE | 54.99 YR | F | 0 | 20160823 | CA |
117882384 | XOLAIR | Nasopharyngitis | ROCHE | 45.51 YR | F | 0 | 20160906 | CA |
118300956 | XOLAIR | Nasopharyngitis | ROCHE | 80.51 YR | M | 0 | 20160929 | CA |
118441674 | XOLAIR | Nasopharyngitis | ROCHE | 66.01 YR | F | 0 | 20160926 | CA |
118607754 | XOLAIR | Nasopharyngitis | NOVARTIS | 20.37 YR | F | 0 | 20160726 | COUNTRY NOT SPECIFIED |
118663806 | XOLAIR | Nasopharyngitis | ROCHE | 69.44 YR | F | 57 KG | 20160915 | CA |
118667424 | XOLAIR | Nasopharyngitis | ROCHE | 20.37 YR | F | 0 | 20160727 | CA |
119153164 | XOLAIR | Nasopharyngitis | ROCHE | 56.86 YR | M | 0 | 20160708 | CA |
Total Records: 171 Number of Pages: 9